New pediatric dosing information for Kaletra.
D000293:Adolescent; D019380:Anti-HIV Agents / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D017277:Drug Approval; D004347:Drug Interactions; D004348:Drug Labeling; D017320:HIV Protease Inhibitors / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D061466:Lopinavir; D008874:Midazolam / Q000008:administration & dosage; D010372:Pediatrics / Q000592:standards*; D011725:Pyridines / Q000008:administration & dosage; D011744:Pyrimidinones / Q000008:administration & dosage*; D011753:Pyrones / Q000008:administration & dosage; D013449:Sulfonamides; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D011725:Pyridines; D011744:Pyrimidinones; D011753:Pyrones; D013449:Sulfonamides; D061466:Lopinavir; D008874:Midazolam; C107201:tipranavir